Clinical trials
Hyperlipidemias trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Chao Yang Hospital | 1 |
| Beijing Suncadia Pharmaceuticals Co., Ltd | 1 |
| CVI Pharmaceuticals | 1 |
| Chinese PLA General Hospital | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
| First Affiliated Hospital of Jinan University | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Guangdong Provincial Hospital of Traditional Chinese Medicine | 1 |
| Huashan Hospital | 1 |
| Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 18 |
| Atherosclerosis | 2 |
| Coronary Artery Disease | 2 |
| Hypertension | 2 |
| Carotid Artery Diseases | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
| Essential Hypertension | 1 |
| Metabolic Syndrome | 1 |
| Periodontitis | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.